These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3624052)

  • 1. Photon activation therapy (PAT).
    Miller RW; DeGraff W; Mitchell JB; Kinsella TJ
    Int J Radiat Oncol Biol Phys; 1987 Sep; 13(9):1429. PubMed ID: 3624052
    [No Abstract]   [Full Text] [Related]  

  • 2. Photon activation therapy.
    Fairchild RG; Bond VP
    Strahlentherapie; 1984 Dec; 160(12):758-63. PubMed ID: 6515666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous infusion of halogenated pyrimidines.
    Rodriguez R; Miller E; Fowler JF; Kinsella TJ
    Int J Radiat Oncol Biol Phys; 1991 Jun; 20(6):1380-2. PubMed ID: 2045313
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical use of radiation sensitizing agents.
    Goffinet DR; Bagshaw MA
    Cancer Treat Rev; 1974 Mar; 1(1):15-26. PubMed ID: 4143475
    [No Abstract]   [Full Text] [Related]  

  • 5. Modification of radiotherapy by radiosensitizers and cancer chemotherapy agents. I. Radiosensitizers.
    Coleman CN
    Semin Oncol; 1989 Jun; 16(3):169-75. PubMed ID: 2658080
    [No Abstract]   [Full Text] [Related]  

  • 6. Radiation enhancement with iodinated deoxyuridine.
    Fairchild RG; Brill AB; Ettinger KV
    Invest Radiol; 1982; 17(4):407-16. PubMed ID: 6813285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1977 Henry H. Janeway lecture: fundamental mechanisms in combined modality therapy of cancer.
    Kaplan HS
    AJR Am J Roentgenol; 1977 Sep; 129(3):383-93. PubMed ID: 409189
    [No Abstract]   [Full Text] [Related]  

  • 8. Radiopharmaceuticals (Strontium 89) and radiosensitizers (idoxuridine).
    Otto SE
    J Intraven Nurs; 1998; 21(6):335-7. PubMed ID: 10392098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of radiation-sensitizing agents in radiation therapy of mouse mammary carcinoma.
    Suit HD; Hewitt R; Urano M
    Radiology; 1970 Jan; 94(1):189-95. PubMed ID: 5410341
    [No Abstract]   [Full Text] [Related]  

  • 10. Opportunities for improving photon radiotherapy.
    Phillips TL
    Hosp Pract (Off Ed); 1985 Aug; 20(8):55-65. PubMed ID: 3926792
    [No Abstract]   [Full Text] [Related]  

  • 11. Concurrent paclitaxel and radiation therapy in the treatment of solid tumors.
    Choy H
    Semin Radiat Oncol; 1999 Apr; 9(2 Suppl 1):1-3. PubMed ID: 10210534
    [No Abstract]   [Full Text] [Related]  

  • 12. [Combined curietherapy and chemotherapy].
    Mazeron JJ
    Cancer Radiother; 1998 Dec; 2(6):781-2. PubMed ID: 9922788
    [No Abstract]   [Full Text] [Related]  

  • 13. The use of halogenated thymidine analogs as clinical radiosensitizers: rationale, current status, and future prospects: non-hypoxic cell sensitizers.
    Kinsella TJ; Mitchell JB; Russo A; Morstyn G; Glatstein E
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1399-406. PubMed ID: 6381432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiobiology and clinical application of halogenated pyrimidine radiosensitizers.
    Mitchell JB; Russo A; Cook JA; Straus KL; Glatstein E
    Int J Radiat Biol; 1989 Nov; 56(5):827-36. PubMed ID: 2573682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical experiences with the use of metronidazole in the radiotherapy of cancer patients].
    Cyb AF; Chmelevskaja ZI; Kudrjavceva GT
    Radiobiol Radiother (Berl); 1985; 26(3):339-42. PubMed ID: 4059519
    [No Abstract]   [Full Text] [Related]  

  • 16. International Clinical Trials in Radiation Oncology. Chemical modifiers.
    Bartelink H; Bleehen NM; Phillips TL
    Int J Radiat Oncol Biol Phys; 1988; 14 Suppl 1():S39-49. PubMed ID: 3292481
    [No Abstract]   [Full Text] [Related]  

  • 17. Modification of radiosensitivity following chemotherapy exposure: potential implications for combined-modality therapy.
    Britten RA
    Cancer Treat Res; 2002; 112():285-303. PubMed ID: 12481721
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical radiosensitization: why it does and does not work.
    Coleman CN; Mitchell JB
    J Clin Oncol; 1999 Jan; 17(1):1-3. PubMed ID: 10458210
    [No Abstract]   [Full Text] [Related]  

  • 19. Polymer-conjugated paclitaxel as a radiosensitizing agent--a big step forward for combined modality therapy?
    Tishler RB
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(3):563-4. PubMed ID: 12573741
    [No Abstract]   [Full Text] [Related]  

  • 20. Tumour radiosensitization with the halogenated pyrimidines 5'-bromo- and 5'-iododeoxyuridine.
    Epstein AH; Cook JA; Goffman T; Glatstein E
    BJR Suppl; 1992; 24():209-14. PubMed ID: 1290703
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.